IP Library › Assignment 017455/0630
Patent Assignment
Reel/Frame 017455/0630

Merger

Recorded: 2006-04-11 Pages: 6
Assignor
EOS BIOTECHNOLOGY, INC.
Executed: 2006-01-09
Assignee
PROTEIN DESIGN LABS, INC.
34801 CAMPUS DRIVE, FREMONT, CALIFORNIA, 94555
Covered Property (1)
Methods of Diagnosis of Ovarian Cancer, Compositions and Methods of Screening for Modulators of Ovarian Cancer
Patent: 7,189,507 →
Application: 10/173,999 →
Publication: US 2004/0005563
Related Assignments (5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Oct 7, 2002
From: MACK, DAVID H.; GISH, KURT C.
To: EOS BIOTECHNOLOGY, INC.
Reel/Frame 013359/0668 →
Change of Name Apr 13, 2006
From: PROTEIN DESIGN LABS, INC.
To: PDL BIOPHARMA, INC.
Reel/Frame 017465/0495 →
Assignment of Assignor's Interest Dec 15, 2009
From: PDL BIOPHARMA, INC.
To: FACET BIOTECH CORPORATION
Reel/Frame 023649/0752 →
Change of Name Dec 7, 2010
From: FACET BIOTECH CORPORATION
To: ABBOTT BIOTHERAPEUTICS CORP.
Reel/Frame 025445/0807 →
Change of Name Sep 18, 2014
From: ABBOTT BIOTHERAPEUTICS CORP
To: ABBVIE BIOTHERAPEUTICS INC
Reel/Frame 033772/0344 →